Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Research Develops Biosensor To Detect Stomach Cancer

This article was originally published in PharmAsia News

Executive Summary

Japanese scientists say they have developed a biosensor small enough to allow a physician to detect a gastrointestinal cancer through an endoscope. The researchers said the sensor on the end of the scope could eliminate the need for tests of blood or tissue samples that take days or weeks to determine the presence of a disease. The biosensor developed by a team at the National Institute of Advanced Industrial Science and Technology detects the presence of a growth factor released by cancer cells to feed a tumor, emitting a light that can be seen in the endoscope. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel